v3.25.1
Details of the NovAlix transaction - Advance (Details) - Drug discovery collaboration transaction with NovAliX
€ in Thousands
12 Months Ended
Dec. 31, 2023
EUR (€)
Ifrs Collaborative Arrangement And Arrangements Other Than Collaborative [Line Items]  
Loss on sale of fixed assets € 12,506
Result of transfer of retirement benefit liability (3,022)
Result of transfer of right-of-use asset 174
Advance related to the NovAliX transaction € 9,658